1989PubMedRequires access

Laboratory diagnostic tests for Alzheimer's disease.

Khalid Iqbal, Gian P. Wang, Inge Grundke‐Iqbal, H. M. Wiśniewski

Open publisher page 5 citations

Abstract

Alzheimer disease/senile dementia of the Alzheimer type (AD/SDAT) is a neuro-degenerative disease which is characterized by the accumulation of paired helical filaments (PHF) in the form of neurofibrillary tangles and neuritic (senile) plaques in the brain. The clinical diagnosis of AD/SDAT is made by excluding other causes of dementia and is uncertain in 10-50% of the cases. The histopathological diagnosis of AD/SDAT can be made only on brain biopsy or after the patient has died on autopsied brain. Presently no laboratory diagnostic test for AD/SDAT is available. Employing a monoclonal antibody to PHF, CSF from clinically diagnosed AD/SDAT and a control group of non-AD/SDAT living patients were probed by a competitive ELISA (enzyme linked immunosorbent assay). The PHF immunoreactivity was found higher in AD/SDAT as compared to control cases suggesting that a laboratory diagnostic test based on this assay might be feasible. Screening of a large number of cases, especially with histopathological confirmation, at multiple AD/SDAT medical centers must be carried out to evaluate the specificity and the sensitivity of the test.

About this research paper

What this paper is about

Alzheimer disease/senile dementia of the Alzheimer type (AD/SDAT) is a neuro-degenerative disease which is characterized by the accumulation of paired helical filaments (PHF) in the form of neurofibrillary tangles and neuritic (senile) plaques in the brain. The clinical diagnosis of AD/SDAT is made by excluding other causes of dementia and is uncertain in 10-50% of the cases. The histopathological diagnosis of AD/SDAT can be made only on brain biopsy or after the patient has died on autopsied brain. Presently no laboratory diagnostic test for AD/SDAT is available. Employing a monoclonal antibody to PHF, CSF from clinically diagnosed AD/SDAT and a control group of non-AD/SDAT living patients were probed by a competitive ELISA (enzyme linked immunosorbent assay). The PHF immunoreactivity was found higher in AD/SDAT as compared to control cases suggesting that a laboratory diagnostic test based on this assay might be feasible. Screening of a large number of cases, especially with histopathological confirmation, at multiple AD/SDAT medical centers must be carried out to evaluate the specificity and the sensitivity of the test.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Alzheimer disease/senile dementia of the Alzheimer type (AD/SDAT) is a neuro-degenerative disease which is characterized by the accumulation of paired helical filaments (PHF) in the form of neurofibrillary tangles and neuritic (senile) plaques in the brain. The clinical diagnosis of AD/SDAT is made by excluding other causes of dementia and is uncertain in 10-50% of the cases. The histopathological diagnosis of AD/SDAT can be made only on brain biopsy or after the patient has died on autopsied brain. Presently no laboratory diagnostic test for AD/SDAT is available. Employing a monoclonal antibody to PHF, CSF from clinically diagnosed AD/SDAT and a control group of non-AD/SDAT living patients were probed by a competitive ELISA (enzyme linked immunosorbent assay). The PHF immunoreactivity was found higher in AD/SDAT as compared to control cases suggesting that a laboratory diagnostic test based on this assay might be feasible. Screening of a large number of cases, especially with histopathological confirmation, at multiple AD/SDAT medical centers must be carried out to evaluate the specificity and the sensitivity of the test.

Key concepts: Alzheimer's disease, Senile plaques, Degenerative disease, Pathology, Medicine, Dementia, Disease, Laboratory test

Related papers

Back to paper searchBrowse research topicsOriginal source
Laboratory diagnostic tests for Alzheimer's disease. — Research Paper | ScholarLens